Whyte M P, Hamm L L, Sly W S
Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110.
J Bone Miner Res. 1988 Aug;3(4):385-8. doi: 10.1002/jbmr.5650030404.
We explored the effects of transfusion of carbonic anhydrase II (CA-II)-replete erythrocytes on systemic pH, serum electrolytes, and urinary acidification of a patient with CA-II deficiency. Pretransfusion studies documented hyperchloremic acidosis, increased urinary pH with decreased titratable acidity, and profound CA-II deficiency in erythrocytes. During transfusion, CA-II in circulating erythrocytes increased to above the half-normal levels seen in asymptomatic heterozygote carriers of CA-II deficiency. However, no significant change occurred in venous, arterial or urinary pH, serum electrolytes, and urinary acid excretion during the transfusion or during the subsequent 60 hr of observation. These studies argue that the renal acidification defect in CA-II deficiency results from deficiency of CA-II in the renal parenchyma, and is not secondary to deficiency of CA-II in erythrocytes. Bone marrow transplantation is not a promising approach to correct the renal manifestations of CA-II deficiency.
我们探讨了输注富含碳酸酐酶II(CA-II)的红细胞对一名CA-II缺乏症患者的全身pH值、血清电解质和尿液酸化的影响。输血前研究记录了高氯性酸中毒、尿pH值升高伴可滴定酸度降低,以及红细胞中CA-II严重缺乏。输血期间,循环红细胞中的CA-II增加至CA-II缺乏无症状杂合子携带者中所见的半正常水平以上。然而,在输血期间或随后60小时的观察期内,静脉、动脉或尿液pH值、血清电解质和尿酸排泄均无显著变化。这些研究表明,CA-II缺乏症中的肾酸化缺陷是由肾实质中CA-II缺乏引起的,而非继发于红细胞中CA-II缺乏。骨髓移植不是纠正CA-II缺乏症肾脏表现的有效方法。